Amsterdam institute for Immunology and Infectious diseases

Free symposium hosted by the Amsterdam Institute of Public Health (APH) where (guest) speakers will present their insights on clinical trial acceleration for drugs and vaccines targeting infectious diseases from different perspectives. The symposium will end with a panel discussion debating the potential for acceleration for all medicines targeting infectious diseases followed by drinks.

Program

• 13:30 Walk-in, coffee and tea
• 14:00 – 14:05 Welcome by Prof. Martin Grobusch, Head of the Center of Tropical and Travel Medicine, Amsterdam UMC
• 14:05 – 14:20 Introduction on APH research on acceleration of clinical trials, dr. Katja de Jong, acceleration research project lead, Amsterdam UMC
• 14:20 – 14:40 Factors associated with acceleration of clinical trial trajectories for infectious diseases, dr. Sabine Hermans, epidemiologist, AIGHD, Amsterdam UMC
• 14:40 – 15:00 The drivers of acceleration through the eyes of key stakeholders, a qualitative analysis, Lois van Eck, bachelor student at VUMC
• 15:00 – 15:20 Perspectives from the industry, dr. Cornelis Winnips, Global Program Clinical Head at Novartis
• 15:20 – 15:35 short break
• 15:35 – 15:50 Perspectives from the European Medicines Agency, speaker to be confirmed
• 15:50 – 16:05 Considerations and challenges from an ethical perspective, speaker from PREPARED consortium
• 16:05 – 16:20 Research Ethics and Research Integrity challenges in accelerated clinical trials, an interview study, Claudia Pallise Perello, PhD candidate at the department of Ethics, law and humanities, Amsterdam UMC
• 16:20 – 17:00 Panel group discussion, chaired by Martin Grobusch
• 17:00 – 17:30 Session closure and drinks